afficher le rapport.

Transcription

National Supply Status for Injectables
Portrait national de la disponibilité des injectables
2016-09-27
Sandoz
Material/
Article
Description
DIN
UPC
Product
Status/
Statut du
Produit
Current
allocation rate /
Taux
d'allocation
actuel
Supply
Status/
Disponibilité
du produit
1020
ACETYLCYSTEINE Sol 200mg/mL 10mLV
02243098
57513010200
P
OA
BO
1030
ACETYLCYSTEINE Sol 200mg/mL 30mLV
02243098
57513010309
P
OA
AV
1011
ALCOHOL (DEHYDRATED) Inj 100% 5x10mLV
00394394
57513010118
P
OA
AV
1070
ALFENTANIL Inj 500mcg/mL 10x2mLV
02248181
57513010705
D
OA
BO
1260
AMIKACIN SO4 Inj 250mg/mL 10x2mLV
02242971
57513012600
P
OA
AV
1282
AMIODARONE HCl for Inj 50mg/mL 10x3mLV
02242325
57513012822
P
OA
AV
1284
AMIODARONE HCl for Inj 50mg/mL 18mLV
02242325
57513012846
P
OA
BO
1285
AMIODARONE HCl for Inj 50mg/mL 9mLV
02242325
57513012853
P
OA
AV
44030148 AMIODARONE SYRINGE for Inj 50mg/mL 1x3mL
02374684
57513213106
P
OA
AV
1330
ATRACURIUM Bes Inj 10mg/mL 10x10mLV
02236759
57513013300
D
OA
BO
1091
ATROPINE SO4 Inj 0.4mg/mL 10x1mLA
00392782
57513010910
P
OA
AV
1101
ATROPINE SO4 Inj 0.6mg/mL 10x1mLA
00392693
57513011016
P
OA
AV
02245458
57513216169
D
OA
BO
44055956 AUROTHIOMALATE Na Inj 50mg/mL 10x1mLA
1650
BRETYLIUM Tos Inj 50mg/mL 5x10mLV
02185377
57513016509
P
OA
AV
11880
CEFAZOLIN for Inj 10gV
02308967
57513118807
P
OA
BO
11870
CEFAZOLIN for Inj 10x1gV
02308959
57513118708
P
OA
AV
11860
CEFAZOLIN for Inj 10x500mgV
02308932
57513118609
P
OA
AV
12000
CEFTRIAXONE for Inj 10gV
02292297
57513120008
P
OA
BO
11970
11980
CEFTRIAXONE for Inj 10x0.25gV
CEFTRIAXONE for Inj 10x1gV
02292262
02292270
57513119705
57513119804
P
P
OA
OA
AV
AV
11990
CEFTRIAXONE for Inj 10x2gV
02292289
57513119903
P
OA
AV
1760
CHLORPROMAZINE HCl Inj 25mg/mL 10x2mLA
00743518
57513017605
D
OA
BO
16190
CIPROFLOXACIN Inj 200mg 10x100mL Minibag
02304759
57513161902
P
OA
AV
16200
CIPROFLOXACIN Inj 400mg 10x200mL Minibag
02304759
57513162008
P
OA
AV
19210
CISPLATIN Inj 1mg/mL 100mLV
02366711
57513192104
P
OA
BO
19200
CISPLATIN Inj 1mg/mL 50mLV
02366711
57513192005
P
OA
AV
02385716
57513214851
S
OA
BO
AV
44045969 CLINDAMYCIN Inj 150mg/mL 10x2mLA
2050
CLINDAMYCIN Inj 150mg/mL 10x2mLV
02230540
57513020506
P
OA
2060
02230540
57513020605
P
OA
AV
2070
02230540
57513020704
S
OA
BO
2090
CLINDAMYCIN Inj 150mg/mL 120mLV
02230535
57513020902
P
OA
AV
2080
CLINDAMYCIN Inj 150mg/mL 60mLV
02230535
57513020803
P
OA
AV
44051274 CLINDAMYCIN Inj 600mg 10x50mL Minibag
02408511
57513215674
P
OA
AV
44051275 CLINDAMYCIN Inj 900mg 10x50mL Minibag
02408538
57513215681
P
OA
AV
44046247 CLINDAMYCIN Inj.150mg/mL 10x4mLA
02385716
57513214875
S
OA
BO
1812
CODEINE PO4 Inj 30mg/mL 10x1mLA
00544884
57513018121
P
OA
AV
2291
DEXAMETHASONE Inj 10mg/mL 10x1mLV
00874582
57513022913
P
OA
AV
2301
7900
44045980
2370
DEXAMETHASONE Inj 4mg/mL 10x5mLV
DIAZEPAM Inj 5mg/mL 10x2mLA
DIAZEPAM Inj. 5mg/mL 10x2mLA
DIGOXIN Inj 0.25mg/mL 10x2mLA
00664227
00399728
02386143
02048264
57513023019
57513079009
57513214813
57513023705
P
P
S
P
OA
OA
OA
OA
AV
AV
BO
AV
02244728
57513216602
P
OA
AV
44059982 DILTIAZEM HCl Inj 5mg/mL 10x10mLV
Anticipated stock depletion date
YYYY-MM-DD /
Date prévue de rupture de stock
AAAA-MM-JJ
Expected
release/
Relâche
prévue
Alternate Material
and Additional Information /
Article de remplacement
et information supplémentaire
Change vs
previous
week/
Changement
vs semaine
précédente
Q2 2017
N/A
―
Q4 2017
N/A
N/A
Mid / mi 2016-10
Stock available at some wholesalers/Inventaire disponible chez
certains grossistes
―
Mid / mi 2016-10
certains grossistes
―
certains grossistes
―
TBD
Mid / mi 2016-10
TBD
TBD
TBD
TBD
Page 1
7900
2016-09-27
Sandoz
Material/
Article
Description
44059958 DILTIAZEM HCl Inj 5mg/mL 10x5mLV
DIN
UPC
Product
Status/
Statut du
Produit
Current
allocation rate /
Taux
d'allocation
actuel
Supply
Status/
Disponibilité
du produit
YYYY-MM-DD /
AAAA-MM-JJ
Expected
release/
Relâche
prévue
02244728
57513216596
P
OA
AV
5901
DIMENHYDRINATE IM Inj 50mg/mL 10x1mLA
00392537
57513059018
P
OA
AV
5841
DIMENHYDRINATE IM Inj 50mg/mL 10x5mLV
00392537
57513058417
P
OA
AV
5831
DIMENHYDRINATE IV Inj 10mg/mL 10x5mLV
00392731
57513058318
P
OA
AV
2400
DIPHENHYDRAMINE HCl Inj 50mg/mL 10x1mLV
00596612
57513024009
P
OA
BO
Q4 2017
2400
DIPHENHYDRAMINE HCl Inj 50mg/mL 10x1mLV
00596612
57513024009
S
OA
BO
TBD
02384671
57513214783
S
OA
BO
TBD
02242010
57513021800
P
OA
AV
44040605 DOCETAXEL Inj 10 mg/mL 16mLV
02439336
57513216121
P
OA
AV
44034081 DOXORUBICIN HCL Inj 2 mg/mL 25 mLV
02375710
57513213267
P
OA
AV
44034080 DOXORUBICIN HCL Inj 2 mg/mL 5x5mLV
44046315 DOBUTAMINE Inj 12.5mg/mL 10x20mLA
2180
DOBUTAMINE Inj 12.5mg/mL 10x20mLV
02375710
57513213250
S
OA
BO
TBD
DROPERIDOL Inj 2.5mg/mL 10x2mLV
02167832
57513021503
D
OA
BO
N/A
2420
EPHEDRINE SO4 Inj 50mg/mL 10x1mLA
00876534
57513024207
P
OA
AV
44030181 ETOPOSIDE for Inj 20mg/mL 10mLV
02380935
57513213069
P
OA
AV
02380935
57513213076
P
OA
AV
02380935
57513213083
P
OA
BO
02380935
57513213052
P
OA
AV
44059966 FENTANYL Cit Inj 50mcg/mL 10x10mLV
02240434
57513216527
P
OA
AV
FENTANYL Cit Inj 50mcg/mL 10x2mLA
02240434
57513025204
P
OA
AV
44045981 FENTANYL Cit Inj 50mcg/mL 10x2mLA
02384124
57513214806
P
OA
AV
44059964 FENTANYL Cit Inj 50mcg/mL 10x5mLV
02240434
57513216510
P
OA
AV
2560
FENTANYL Cit Inj 50mcg/mL 50mLV
02240434
57513025600
P
OA
AV
2540
FENTANYL Cit Inj 50mcg/mL 5x10mLV
02240434
57513025402
S
OA
BO
2550
FENTANYL Cit Inj 50mcg/mL 5x20mLV
02240434
57513025501
P
OA
AV
44045968 FENTANYL Cit Inj. 50mcg/mL 5x10mLA
02384124
57513214790
S
OA
BO
44046009 FLUCONAZOLE Inj 2mg/mL 100mLV
02388448
57513214639
P
OA
AV
2490
FLUCONAZOLE Inj 2mg/mL 100mLV
02248443
57513024900
S
OA
BO
2630
FLUMAZENIL Inj 0.1mg/mL 10x5mLV
02249561
57513026300
P
OA
AV
17890
FLUOROURACIL Inj 50mg/mL 100mLV
00012882
57513178900
P
OA
AV
02382539
57513214752
P
OA
AV
44046153 FUROSEMIDE 10MG/ML 4ML 10LIAM CA
2440
FUROSEMIDE Inj 10mg/mL 10x2mLA
00527033
57513024405
S
OA
BO
2451
FUROSEMIDE Inj 10mg/mL 10x4mLV
00527033
57513024511
P
OA
AV
44046010 FUROSEMIDE Inj. 10mg/mL 10x2mLA
02382539
57513214745
P
OA
AV
00401633
57513024610
P
OA
AV
44029386 Gemcitabine HCL for Inj 40mg/mL 1x25mLV
02412292
57513212765
P
OA
AV
02412292
57513212758
P
OA
AV
02412292
57513212772
P
OA
AV
2461
FUROSEMIDE SPECIAL Inj 10mg/mL 10x25mLV
2780
GENTAMICIN Inj 10mg/mL 10x2mLV
02268531
57513027802
P
OA
AV
2800
GENTAMICIN Inj 40mg/mL 10x2mLV
02242652
57513028007
P
OA
AV
2810
GENTAMICIN Inj 40mg/mL 20mLV
02242652
57513028106
P
OA
AV
2871
GLYCOPYRROLATE Inj 0.2mg/mL 10x2mLV
02039508
57513028717
P
OA
AV
2880
GLYCOPYRROLATE Inj 0.2mg/mL 20mLV
02039508
57513028809
P
OA
AV
2900
HALOPERIDOL Inj 5mg/mL 10x1mLA
00808652
57513029004
P
OA
AV
2180
End / fin 2016-10
certains grossistes
N/A
44059966
TBD
2540
TBD
TBD
Page 2
Change vs
previous
week/
Changement
vs semaine
précédente
―
New product available/Nouveau produit disponible
2150
2520
Alternate Material
44046010
2016-09-27
Sandoz
Material/
Article
Description
DIN
UPC
Product
Status/
Statut du
Produit
Current
allocation rate /
Taux
d'allocation
actuel
Supply
Status/
Disponibilité
du produit
2940
HALOPERIDOL LA Inj 100mg/mL 5mLV
02130300
57513029400
P
OA
AV
10990
HEPARIN Na 10 000U/mL 50mLV
02303108
57513109904
P
OA
AV
10730
HEPARIN Na Inj 10,000U/mL 10x1mLV
02303094
57513107306
P
OA
AV
10740
HEPARIN Na Inj 10,000U/mL 10x5mLV
02303108
57513107405
P
OA
AV
10750
HEPARIN Na Inj 1000U/mL 10x10mLV
02303086
57513107504
P
OA
AV
10760
HEPARIN Na Inj 1000U/mL 10x30mLV
02303086
57513107603
P
OA
AV
4021
HYDROMORPHONE HCl Inj 2mg/mL 10x1mLA
02145901
57513040214
P
OA
AV
4152
HYDROMORPHONE HP FORTE Inj 10mLV
02244797
57513041525
P
OA
BO
4031
HYDROMORPHONE HP10 Inj 10x1mLV
02145928
57513040313
P
OA
AV
44059959 HYDROMORPHONE HP10 Inj 10x5mLV
YYYY-MM-DD /
AAAA-MM-JJ
Expected
release/
Relâche
prévue
02145928
57513216589
P
OA
AV
HYDROMORPHONE HP10 Inj 50mLV
02145928
57513040610
P
OA
AV
4101
02145936
57513041013
P
OA
AV
4111
HYDROMORPHONE HP50 Inj 10x1mLV
02146126
57513041112
P
OA
AV
4141
02146126
57513041419
P
OA
AV
3000
HYDROXYZINE HCl Inj 50mg/mL 10x1mLA
00742813
57513030000
P
OA
AV
3200
HYOSCINE Butylbr Inj 20mg/mL 10x1mLV
02229868
57513032004
P
OA
AV
44060082 IMIPENEM/CILASTATIN for Inj 10x250mgV
02358336
57513216503
P
OA
BO
Mid / mi 2016-11
19320
IMIPENEM/CILASTATIN for Inj 10x500mgV
44035276 IRINOTECAN HCl Inj 20mg/mL 5x2mLV
44035277 IRINOTECAN HCl Inj 20mg/mL 5x5mLV
02358344
02305143
02305143
57513193200
57513213700
57513213717
P
S
S
OA
OA
OA
BO
BO
BO
End / fin 2016-09
TBD
TBD
44035278 IRINOTECAN HCl Inj. 20mg/mL 25mLV
TBD
02305143
57513213724
S
OA
BO
ISOPROTERENOL HCl Inj 0.2mg/mL 10x1mLA
00897639
57513046001
P
OA
AV
13740
KETAMINE HCl Inj 10mg/mL 10x2mLV
02246795
57513137402
P
OA
AV
4550
KETAMINE HCl Inj 10mg/mL 20mLV
02246795
57513045509
P
OA
AV
4560
KETAMINE HCl Inj 50mg/mL 10mLV
02246796
57513045608
P
OA
AV
02387336
57513214837
S
OA
BO
44046082 KETAMINE HCl Inj 50mg/mL 10x2mLA
13750
KETAMINE HCl Inj 50mg/mL 10x2mLV
02246796
57513137501
P
OA
AV
4640
KETOROLAC Trometh Inj 30mg/mL 10x1mLV
02239944
57513046407
P
OA
BO
4660
LABETALOL HCl Inj 5mg/mL 20mLV
02231689
57513046605
P
OA
AV
44059850 LORAZEPAM Inj 2mg/mL 10x1mLV
02438704
57513216473
P
OA
AV
4970
LORAZEPAM Inj 4mg/mL 10x1mLV
02243278
57513049705
P
OA
AV
5000
LOXAPAC IM Inj 50mg/mL 10x1mLA
02169991
57513050008
P
OA
AV
2201
MEPERIDINE HCl Inj 50mg/mL 10x1mLA
00725765
57513022012
P
OA
AV
19190
MEROPENEM for Injection 10x1g/V
02378795
57513191909
P
OA
AV
19180
MEROPENEM for Injection 10x500mg/V
02378787
57513191800
P
OA
AV
44037415 METHOTREXATE Inj 25mg/mL 20mLV
02398427
57513213915
P
OA
AV
44037414 METHOTREXATE Inj 25mg/mL 2mLV
02398427
57513213908
P
OA
AV
5200
METOCLOPRAMIDE HCl Inj 5mg/mL 10x2mLV
02185431
57513052002
P
OA
AV
5220
METOCLOPRAMIDE HCl Inj 5mg/mL 30mLV
02185431
57513052200
P
OA
AV
02267853
57513216541
P
OA
AV
02240285
57513052507
P
OA
AV
02382873
57513214721
S
OA
BO
02240285
57513052309
P
OA
AV
44059967 METOPROLOL Tart Inj 1mg/mL 10x5mLV
5250
MIDAZOLAM Inj 1mg/mL 10x10mLV
44046184 MIDAZOLAM Inj 1mg/mL 10x2mLA
5230
Change vs
previous
week/
Changement
vs semaine
précédente
Mid / mi 2016-10
4061
4600
Alternate Material
TBD
certains grossistes
13750
―
Q1 2017
TBD
Page 3
5230
2016-09-27
Sandoz
Material/
Article
Description
DIN
UPC
Product
Status/
Statut du
Produit
Current
allocation rate /
Taux
d'allocation
actuel
Supply
Status/
Disponibilité
du produit
AV
5240
02240285
57513052408
P
OA
5280
02240286
57513052804
P
OA
AV
02382903
57513214684
S
OA
BO
02240286
57513052606
P
OA
AV
5260
57513214691
S
OA
BO
5270
02240286
57513052705
P
OA
AV
5281
MIDAZOLAM Inj 5mg/mL 50mLV
02240286
57513052811
P
OA
AV
5370
MILRINONE Lactate Inj 1mg/mL 10x10mLV
02244854
57513053702
P
OA
AV
5530
MORPHINE HP50 Inj 50mg/mL 10x1mLV
00617288
57513055300
P
OA
AV
5560
MORPHINE HP50 Inj 50mg/mL 50mLV
00617288
57513055607
P
OA
AV
5550
MORPHINE HP50 Inj 50mg/mL 5x10mLV
00617288
57513055508
P
OA
AV
44059961 MORPHINE LP EPID Inj 0.5mg/mL 10x10mLV
02021056
57513216572
P
OA
AV
44059962 MORPHINE LP EPID Inj 1mg/mL 10x5mLV
02021048
57513216565
P
OA
AV
MORPHINE SO4 Inj 10mg/mL 10x1mLA
00392588
57513054426
P
OA
AV
44045762 MORPHINE SO4 Inj 10mg/mL 10x1mLA
02382997
57513214943
P
OA
AV
5442
02382903
5452
00392561
57513054525
P
OA
AV
5642
02242484
57513056420
P
OA
AV
6401
MULTI-1000 Inj 10x10mLV
00586315
57513064012
P
OA
AV
5760
NALOXONE HCl Inj 0.4mg/mL 10mLV
02148706
57513057601
P
OA
AV
5750
NALOXONE HCl Inj 0.4mg/mL 10x1mLA
02148706
57513057502
P
OA
AV
44046084 NALOXONE HCl Inj 0.4mg/mL 10x1mLA
02382601
57513214677
S
OA
BO
YYYY-MM-DD /
AAAA-MM-JJ
Expected
release/
Relâche
prévue
Alternate Material
TBD
5260
TBD
5270
TBD
5750
5770
NALOXONE HCl Inj 1mg/mL 10x2mLV
02148714
57513057700
P
OA
AV
5940
NEOSTIGMINE MeSO4 Inj 2.5mg/mL 10x5mLV
01915436
57513059407
D
OA
BO
5972
NOREPINEPHRINE Bitart Inj 1mg/mL 10x4mLV
00893285
57513059728
P
OA
AV
11310
NUBAIN Inj 10mg/mL 10x1mLA
01913980
57513113109
P
OA
AV
02416522
57513216312
P
OA
AV
ONDANSETRON Inj 2mg/mL 10x2mLV
02279428
57513111501
P
OA
AV
44059968 ONDANSETRON Inj 2mg/mL 10x4mLV
02279428
57513216626
P
OA
AV
02279436
57513111709
P
OA
AV
44045669 ONDANSETRON Inj 2mg/mL 5x2mLA
02274418
57513214615
P
OA
BO
End / fin 2016-09
44045668 ONDANSETRON Inj 2mg/mL 5x4mLA
02274418
57513214608
S
OA
BO
TBD
44070026 OXALIPLATIN Inj 5mg/mL 10mLV
02436957
57513216909
P
OA
AV
02436957
57513216886
P
OA
AV
02436957
57513216978
P
OA
AV
02436957
57513217623
P
OA
AV
02436957
57513216893
S
OA
BO
44034377 PACLITAXEL Inj 6mg/mL 1x16.7mLV
02320150
57513216657
P
OA
AV
44034379 PACLITAXEL Inj 6mg/mL 1x50mLV
02320150
57513216671
P
OA
AV
44034376 PACLITAXEL Inj 6mg/mL 5x5mLV
02320150
57513216725
P
OA
AV
44057493 OLANZAPINE for Injection 1x10mg/V
11150
11170
ONDANSETRON Inj 2mg/mL 20mLV
12395
PANTOPRAZOLE Na for Inj 10x40mgV
02306727
57513123955
P
OA
AV
9860
PAPAVERINE HCl Inj 32.5mg/mL 10x2mLV
00009881
57513098604
P
OA
AV
11240
PHENOBARBITAL Na Inj 120mg/mL 10x1mLA
02304090
57513112409
P
OA
AV
11230
PHENOBARBITAL Na Inj 30mg/mL 10x1mLA
02304082
57513112300
P
OA
AV
N/A
certains grossistes
New format available / Nouveau format disponible
N/A
Page 4
44070023
Change vs
previous
week/
Changement
vs semaine
précédente
2016-09-27
Sandoz
Material/
Article
Description
DIN
UPC
Product
Status/
Statut du
Produit
Current
allocation rate /
Taux
d'allocation
actuel
Supply
Status/
Disponibilité
du produit
6120
PHENTOLAMINE Mes Inj 5mg/mL 10x1mLV
02243737
57513061202
P
OA
AV
6171
PHENYLEPHRINE HCl Inj 10mg/mL 10x1mLV
01953583
57513061714
P
OA
AV
6181
PHENYLEPHRINE HCl Inj 10mg/mL 10x5mLV
01953583
57513061813
P
OA
AV
6200
PHENYTOIN Na Inj 50mg/mL 10x2mLV
00780626
57513062001
P
OA
AV
6211
PHENYTOIN Na Inj 50mg/mL 10x5mLV
00780626
57513062117
P
OA
AV
12450
PIPERACILLIN-TAZO for Inj 10x2.25gV
02299623
57513124501
P
OA
AV
12460
02299631
57513124600
P
OA
AV
12470
02299658
57513124709
P
OA
BO
12475
PIPERACILLIN-TAZO Inj PWD 13.5g/Vx1
02330547
57513124754
P
OA
AV
02184486
57513216619
P
OA
AV
44059963 PROCAINAMIDE HCl Inj 100mg/mL 10x10mLV
6690
PROMETHAZINE HCl Inj 25mg/mL 10x1mLA
00567434
57513066900
D
OA
BO
7000
PROPRANOLOL HCl Inj 1mg/mL 10x1mLV
02225883
57513070006
P
OA
AV
7060
PROTAMINE SO4 Inj 10mg/mL 10x5mLV
02231674
57513070600
P
OA
AV
7070
PROTAMINE SO4 Inj 10mg/mL 25mLV
02231674
57513070709
P
OA
AV
7250
RANITIDINE Inj 25mg/mL 10x2mLV
02256711
57513072505
P
OA
AV
7260
RANITIDINE Inj 25mg/mL 50mLV
02256711
57513072604
P
OA
AV
11250
ROCURONIUM Br Inj 10mg/mL 10x5mLV
02318415
57513112508
P
OA
AV
02453258
57513217753
P
OA
AV
SUFENTANIL Cit Inj 50mcg/mL 10x1mLA
02244147
57513078705
P
OA
AV
44059965 SUFENTANIL Cit Inj 50mcg/mL 10x5mLV
02244147
57513216534
P
OA
AV
44067635 TOBRAMYCIN INH SOL 300mg/5mL x 56 Amp
02443368
57513217401
P
OA
AV
44071497 SOS Naloxone HCl 0.4 mg/mL 1mL x 10 Amp
7870
YYYY-MM-DD /
AAAA-MM-JJ
Expected
release/
Relâche
prévue
Alternate Material
End / fin 2016-09
certains grossistes
N/A
8660
TOBRAMYCIN Inj 10mg/mL 10x2mLV
02241209
57513086601
P
OA
AV
8680
TOBRAMYCIN Inj 40mg/mL 30mLV
02241210
57513086809
P
OA
BO
8650
TOBRAMYCIN PF Inj 40mg/mL 10x2mLV
02241210
57513086502
P
OA
AV
02390981
57513214219
P
OA
AV
02246365
57513080609
P
OA
AV
8070
TRANEXAMIC ACID Inj 100mg/mL 50mLV
44040859 VANCOMYCIN HCl for Inj 10gV
02246365
02394650
57513080708
57513214295
P
P
OA
OA
AV
BO
TBD
44059200 VANCOMYCIN HCl for Inj 1gx10V
02394634
57513214271
P
OA
BO
Mid / mi 2016-10
44059199 VANCOMYCIN HCl for Inj 500mgx10V
02394626
57513214264
P
OA
AV
44040860 VANCOMYCIN HCl for Inj 5gV
02394642
57513214288
P
OA
AV
44032350 Topotecan HCl Inj. 1mg/mL 5x4mLV
8060
TRANEXAMIC ACID Inj 100mg/mL 10x10mLV
8910
VASOPRESSIN Inj 20 USP units/mL 5mLV
02247938
57513089107
P
OA
AV
12670
VASOTEC IV Inj 1.25mg/mL 2mLV
01923846
57513126703
P
OA
AV
8960
VERAPAMIL HCl Inj 2.5mg/mL 10x2mLV
02166739
57513089602
P
OA
AV
9051
VITAMIN B12 Inj 1000mcg/mL 10mLV
00521515
57513090516
P
OA
AV
9040
VITAMIN B12 Inj 1000mcg/mL 10x1mLA
00521515
57513090400
P
OA
AV
9060
VITAMIN B12 Inj 1000mcg/mL 30mLV
00521515
57513090608
P
OA
AV
9030
VITAMIN B12 Inj 100mcg/mL 10x1mLA
02241500
57513090301
P
OA
AV
1000
VITAMIN C Inj 250mg/mL 10x2mLA
00780634
57513010002
P
OA
AV
44047435 VORICONAZOLE for Inj 200mgV
02381966
57513215070
P
OA
AV
44051756 ZOLEDRONIC ACID Inj 4mg/5mLV
02401606
57513215452
P
OA
AV
Q4 2016
Page 5
certains grossistes
Change vs
previous
week/
Changement
vs semaine
précédente
2016-09-27
Sandoz
Material/
Article
Description
DIN
UPC
Product
Status/
Statut du
Produit
Current
allocation rate /
Taux
d'allocation
actuel
Legend
Légende
Description
Description
LIVI
Liquid in vial
Liquide en fiole
LIAM
Liquid in Ampoule
Liquide en ampoule
LYVI
Lyophilisate in vial
Lyophilisée en fiole
PSOIJ
Powder for solution for injection/ infusion
DIN: Leading zeros have been removed
Poudre pour solution injectable
DIN: Les zéros non-significatifs du début ont été retirés
Product Status
Statut du produit
P
In production
En production
S
Suspended format
Format suspendu
S1
Suspended format prioritized for return in production
Format suspendu priorisé pour la remise en production
D
Discontinued
Current allocation rate
Discontinué
Taux d'allocation actuel
OA
Off allocation
Supply Status
N'est pas en allocation
Disponibilité du produit
AV
Available
Disponible
ABO
Anticipated backorder in the next 90 days
Rupture de stock prévue dans les prochains 90 jours
BO
EM
On backorder
Emergency use only. Customers must order directly
through Sandoz Canada by completing and submitting
an "Exceeding Allocation Order" (EAO) form.
En rupture de stock
Cas d'urgence seulement. Les clients doivent commander
directement chez Sandoz Canada en complétant le formulaire
"Commande excédant les allocations" (CEA).
Limited stock
Approvisionnement limité
Insufficient stock
Alternate Material & Additional Information
Approvisionnement insuffisant
Article de remplacement & information supplémentaire
Change vs previous week
Positive change on P product status since previous report
(ex: increased allocation %, later stock depletion date,
improved release date)
Negative change on P product status since previous report
(ex: decreased allocation %, sooner stock depletion date,
later release date)
Changement vs semaine précédente
Changement positif de l'état du produit P depuis le rapport
précédent (ex: taux d'allocation augmenté, date prévue de
rupture de stock repoussée, relâche prévue devancée)
Changement négatif de l'état du produit P depuis le rapport
précédent (ex: taux d'allocation réduit, date prévue de rupture
de stock devancée, relâche prévue repoussée)
+
―
Supply
Status/
Disponibilité
du produit
Page 6
YYYY-MM-DD /
AAAA-MM-JJ
Expected
release/
Relâche
prévue
Alternate Material
Change vs
previous
week/
Changement
vs semaine
précédente
2016-09-27
ABO definition
Additional Information
Anticipated backorder dates (ABO) are calculated based on projected national consumption. The actual backorder date at a
customer's specific warehouse may differ from the ABO date indicated on this report.
ABO - définition
Information supplémentaire
Les dates de ruptures de stock prévues (ABO) sont établies à partir d'une projection de consommation nationale.
BO definition
Products are indicated as being on backorder (BO) as soon as the inventory level at the main Sandoz warehouse is less
than a pre-determined threshold. There may still be inventory left in some warehouses. Customers are encouraged to verify
the inventory status at their usual purchase point.
BO - définition
Les produits sont déclarés en rupture (BO) à partir du moment où le niveau d'inventaire dans l'entrepôt principal de Sandoz
franchit un seuil pré-déterminé. Certains entrepôts à travers le pays peuvent encore avoir des quantités en inventaire.
Les clients sont priés de vérifier le statut d'inventaire à leur point d'achat habituel.
Processing of BO
products in the
allocation tables
Where an alternative exists. Where an alternate product for a product on BO exists, the purchasing history of the BO
product has been included in the purchasing history of the alternate product, with an adjustment in allocation for the
alternate product. The transfer is now identifiable in the new column "Sandoz Alternate Material", where the alternate
product # is indicated. In the case of a temporary BO, the transfer of quantities is temporary and allocation quantities of the
original product become available again once the original product returns in stock.
Traitement des produits
en rupture dans les
tables d'allocation
Lorsqu'un produit de remplacement existe. Si un produit de remplacement existe au moment de la rupture d'un produit,
l'historique d'achat du produit en rupture est ajouté à l'historique d'achat du produit de remplacement, ajustant à la hausse
l'allocation du produit de remplacement. Le transfert est indiqué dans la nouvelle colonne «Article de remplacement
Sandoz», où est inscrit le numéro du produit de remplacement. Dans le cas d'une rupture temporaire, le transfert des
quantités est temporaire et les quantités allouées pour le produit original seront rétablies lors de son retour en stock.
Example:
Exemple:
When product 2090 CLINDAMYCIN 150MG/ML 1 vial x 120ML fell on BO, the sales history of that product was transferred
to product 2080 CLINDAMYCIN 150MG/ML 1 vial x 60ML. Since the original format (120ml) contains twice as much
volume as the alternate format (60ml), the transferred quantities were calculated as follows:
Lorsque le produit 2090 CLINDAMYCIN 150MG/ML 1 fiole x 120ML est tombé en rupture, son historique d'achat a été
transféré au produit 2080 CLINDAMYCIN 150MG/ML 1 fiole x 60ML. Étant donné que le volume du format original (120ml)
est deux fois plus grand que le volume du format de remplacement (60ml), le transfert de quantités a été calculé de la
façon suivante:
Historique d'achat de 2090 CLINDAMYCIN 150MG/ML 1 fiole x 120ML:
100 unités
Historique d'achat de 2080 CLINDAMYCIN 150MG/ML 1 fiole x 60ML:
400 unités
Historique d'achat de 2090 converti en unités équivalentes du 2080:
100 * 2 = 200 unités
Nouvel historique d'achat de 2080:
400 + 200 = 600 unités
Sales history of 2090 CLINDAMYCIN 150MG/ML 1 vial x 120ML:
Sales history of 2080 CLINDAMYCIN 150MG/ML 1 vial x 60ML:
Sales history of 2090 converted to equivalent quantities in 2080:
New sales history of 2080:
Possible discrepancies
between this report and
quantities shipped to
customers
100 units
400 units
100 * 2 = 200 units
400 + 200 = 600 units
Where no alternative exists. Products in production ("P" status) which are on short-term BO and for which an alternate
product has NOT been identified are included in the allocation tables and continue to show quantities which can be
ordered. Their inclusion is necessary to allow customers to order the product as soon as it becomes available again without
having to wait for the following allocation cycle.
Lorsqu'aucun produit de remplacement n'a été identifié. Les produits en production (statut «P») qui sont en rupture à
court terme et pour lesquels aucun remplacement n'est disponible sont inclus dans les tables d'allocation et continuent
d'afficher des quantités qui peuvent être commandées. Ceci permet aux clients de commander le produit dès qu'il est
disponible à nouveau sans devoir attendre le prochain cycle d'allocation.
Suspended or discontinued products. Products that are suspended or discontinued ("S" and "D" status) which are on
BO are removed from the allocation tables.
Produits suspendus ou discontinués. Les produits suspendus ou discontinués (statuts «S» et «D») qui sont en rupture
sont retirés des tables d'allocation.
Discrepancies may occur between the product status (ex: AV, BO) and allocation rate indicated on this report and actual
quantities shipped. For example:
- Some products on short-term BO continue to appear on the allocation tables (as described above).
- Disruptions in the replenishment of the distribution centers may cause delays in having product available in time for the
allocation cycles. Customers are encouraged to order the product again.
Depletion of suspended
and discontinued
products
Inventory depletion of suspended ("S" status) and discontinued ("D" status) products are indicated as follows:
- The ABO is indicated when the backorder is anticipated to occur in the next 90 days (based on projected national
consumption).
Des divergences peuvent survenir entre le statut des produits (ex: AV, BO) et le taux d'allocation indiqués dans ce rapport
Différences possibles
et les quantités réelles expédiées aux clients. Par exemple:
entre ce rapport et les
quantités expédiées aux
- Certains produits qui sont en rupture à court terme continuent d'afficher des quantités dans les tables d'allocation (tel que
clients
décrit précédemment).
- Des interruptions dans le réapprovisionnement des entrepôts peuvent retarder la disponiblité des produits pour le cycle
d'allocation. Les clients sont priés de commander à nouveau.
Écoulement des produits L'écoulement d'inventaire des produits suspendus (statut «S») et discontinués (statut «D») est indiqué de la façon suivante:
suspendus et
- La rupture prévue (ABO) est déclarée lorsqu'elle est prévue au cours des 90 prochains jours (basé sur une projection de
discontinués
consommation nationale).
- As soon as the inventory level at the main Sandoz warehouse is less than a pre-determined threshold, the status changes
to BO and the product is removed from allocation (OA). There may still be inventory left in some warehouses, in which
case customers will be able to order the remaining quantities until depletion at their purchase point.
- À partir du moment où le niveau d'inventaire dans l'entrepôt principal de Sandoz franchit un seuil pré-déterminé, le produit
est déclaré en rupture (BO), puis est retiré de l'allocation (OA). Certains entrepôts à travers le pays peuvent encore avoir
des produits en inventaire. Les clients pourront dans ce cas commander les quantités restantes jusqu'à épuisement des
stocks à leur point d'achat.
- The projected return date for suspended products is indicated in the "Expected release"column.
- La date de retour prévue des produits suspendus est indiquée dans la colonne «Relâche prévue».

afficher le rapport.

Transcription

Documents pareils

le Rapport - La Ville Des Cayes

PETHIDINE RENAUDIN 50mg/ml SOL INJ AMP 2ml B/10

FORTUM ENFANTS ET NOURRISSONS 500mg PDR SOL INJ IM IV

FORTUM 2g PDR SOL INJ IV FL/1

RENCONTREZ LA SNC

CALENDRIER LIGUE NORD PAS DE CALAIS DE JUDO 2012-2013

Commune de Chiconi

Sécurisation de l`utilisation des solutions concentrées de potassium

Internes et informatique

Médicaments à haut risque